scholarly journals Comparison of the resonance sonorheometry based Quantra® system with rotational thromboelastometry ROTEM® sigma in cardiac surgery – a prospective observational study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Werner Baulig ◽  
Samira Akbas ◽  
Philipp K. Schütt ◽  
Wolfgang Keul ◽  
Marija Jovic ◽  
...  

Abstract Background Measures of the sonorheometry based Quantra® viscoelastic hemostatic analyzer (HemoSonics, LCC, Charlottesville, VA, USA) were compared with corresponding results of the ROTEM® sigma device (Instrumentation Laboratory, Bedford, MA, USA). Methods In thirty-eight patients scheduled for elective cardiac surgery between December 2018 and October 2019, blood samples were taken after induction of anesthesia (sample 1) and after heparin neutralization (sample 2) and measured on Quantra (QPlus® Cartridge) and ROTEM sigma (ROTEM® sigma complete + hep Cartridge). Clot times and clot stiffness values were recorded. Clot stiffness values of ROTEM amplitudes (A in mm) were converted to shear modulus (G) in hectoPascal (hPa): G (hPa) = (5 x A)/(100-A). Additionally, time-to-results was recorded. Spearman rank test correlation and Bland Altman analysis were performed. Results Clot stiffness parameters of the Quantra correlated strongly with corresponding measurements of the ROTEM with r = 0.93 and 0.94 for EXTEM A10 vs CS and r = 0.94 and 0.96 for FIBTEM A10 vs FCS for sample 1 and 2, respectively. Quantra clot time correlated strongly with ROTEM INTEM CT with r = 0.71 for sample 1 and r = 0.75 for sample 2. However, Bland Altman analysis showed no agreement in all compared assays of both methods. The median time to delivery of first and complete results was significantly shorter for Quantra (412 and 658 s) compared to ROTEM sigma (839 and 1290 s). Conclusions The Quantra showed a strong correlation with the ROTEM sigma for determining clot times and clot stiffness and the parameters assess similar aspects of clot development. However, these parameters are not directly interchangeable and implicate that separate cut-off values need to be established for users of the Quantra device. Word count: 278. Trial registration The study was retrospectively registered with ClinicalTrials.gov (ID: NCT04210830) at December 20th 2019.

2020 ◽  
Vol 68 (8) ◽  
pp. 754-761
Author(s):  
Hayato Ise ◽  
Hiroto Kitahara ◽  
Kyohei Oyama ◽  
Keiya Takahashi ◽  
Hirotsugu Kanda ◽  
...  

Abstract Objectives Hypothermic circulatory arrest (HCA) has been considered to cause coagulopathy during cardiac surgery. However, coagulopathy associated with HCA has not been understood clearly in details. The objective of this study is to analyze the details of coagulopathy related to HCA in cardiac surgery by using rotational thromboelastometry (ROTEM). Methods We retrospectively analyzed 38 patients who underwent elective cardiac surgery (HCA group = 12, non-HCA group = 26) in our hospital. Blood samples were collected before and after cardiopulmonary bypass (CPB). Standard laboratory tests (SLTs) and ROTEM were performed. We performed four ROTEM assays (EXTEM, INTEM, HEPTEM and FIBTEM) and analyzed the following ROTEM parameters: clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF) and maximum clot elasticity (MCE). The amount of perioperative bleeding, intraoperative transfusion and perioperative data were compared between the HCA and non-HCA group. Results Operation time and hemostatic time were significantly longer in the HCA group, whereas CPB time had no difference between the groups. The amount of perioperative bleeding and intraoperative transfusion were much higher in the HCA group. SLTs showed no difference between the groups both after anesthesia induction and after protamine reversal. In ROTEM analysis, MCE contributed by platelet was reduced in the HCA group, whereas MCE contributed by fibrinogen had no difference. Conclusion Our study confirmed that the amount of perioperative bleeding and intraoperative transfusion were significantly higher in the HCA group. ROTEM analysis would indicate that clot firmness contributed by platelet component is reduced by HCA in cardiac surgery.


2017 ◽  
Vol 46 (2) ◽  
pp. 873-882 ◽  
Author(s):  
Jung Min Lee ◽  
Eun Young Park ◽  
Kyung Mi Kim ◽  
Jong Chan Won ◽  
Tack Koon Jung ◽  
...  

Objective This study compared the activated clotting time (ACT) measured using the Hemochron Jr. Signature (HACT) with the ACT measured using the Medtronic ACT Plus (MACT) during cardiopulmonary bypass (CPB) with acute normovolemic haemodilution (ANH) in patients undergoing cardiac surgery. Methods The ACT was checked at baseline with both devices after inducing anaesthesia, and 400 to 800 mL of whole blood was withdrawn to induce moderate ANH. Before initiating CPB, a 300-IU/kg bolus dose of heparin was administered to maintain the HACT at >400 s; protamine was later given to reverse the anticoagulation. The ACT was checked using both devices at baseline, during heparinisation, and after protamine administration. Results In total, 106 pairs of samples from 29 patients were analysed. The ACT showed a good correlation between the two devices (r = 0.956). However, Bland–Altman analysis showed that the MACT was higher, particularly at baseline and during heparinisation. Multiple regression analysis showed that the blood glucose concentration significantly influenced the differences between the two ACT devices. Conclusions The HACT was lower than the MACT during CPB with ANH in patients undergoing cardiac surgery. Clinicians should be cautious when using each ACT device within generally accepted reference ACT values.


2016 ◽  
Vol 23 (1) ◽  
pp. 20-26 ◽  
Author(s):  
Omer Dzemali ◽  
Michael T. Ganter ◽  
Alicja Zientara ◽  
Kirk Graves ◽  
Renate Behr ◽  
...  

Background: Sonoclot is used to measure kaolin-based activated clotting time (kACT) for heparin management. Apart from measuring kACT, the device assesses the patient’s coagulation status by glass bead–activated tests (gbACTs; measuring also clot rate [CR] and platelet function [PF]). Recently, a new version of the Sonoclot has been released, and the redesign may result in performance changes. The aim of this study was to evaluate and compare the performance of the new (S2) and the previous (S1) Sonoclot. Methods: The S1 was used in the routine management of 30 patients undergoing elective cardiac surgery. Blood samples were taken at baseline (T1), after heparin administration (200 U/kg, 100 U/kg; T2 and T3), during cardiopulmonary bypass (T4), after protamine infusion (T5), and before intensive care unit transfer (T6). Kaolin-based activated clotting time and gbACTs were measured in duplicate by both the old and the new device and performance compared by Bland-Altman analysis and percentage error calculation. Results: A total of 300 kACT and 180 gbACTs were available. Bland-Altman analysis for kACT revealed that S2 consistently reported results in shorter time compared to S1 (overall = −14.7%). Comparing S2 and S1, the glass bead–activated tests showed mean percentage differences of −18.9% (gbACTs), +37.4% (CR), and −3.7% (PF). Conclusion: Since clotting is faster in the new S2 compared to S1, shorter clotting times have to be considered in clinical practice. The use of S2 kACT in heparin management will result in higher heparin and protamine dosing unless heparin kACT target values are adjusted to correct for the differences in results between S1 and S2.


Perfusion ◽  
2021 ◽  
pp. 026765912199854
Author(s):  
Helena Argiriadou ◽  
Polychronis Antonitsis ◽  
Anna Gkiouliava ◽  
Evangelia Papapostolou ◽  
Apostolos Deliopoulos ◽  
...  

Introduction: Coagulopathy after cardiac surgery is a serious multifactorial complication that results in postoperative bleeding requiring transfusion of red blood cells and procoagulant products. Use of cardiopulmonary bypass represents the major contributing factor affecting coagulation. We sought to prospectively investigate the effect of contemporary minimal invasive extracorporeal circulation (MiECC) on coagulation parameters using point-of-care (POC) rotational thromboelastometry and the relation to postoperative bleeding. Methods: Patients undergoing elective cardiac surgery on MiECC were prospectively recruited. Anticoagulation strategy was based on individualized heparin management and heparin level-guided protamine titration. Rotational thromboelastometry testing was performed before induction of anesthesia and after aortic cross-clamp release. A strict POC-guided transfusion protocol was implemented. The primary endpoint was the assessment of viscoelastic properties of the coagulating blood at the end of surgery compared to preoperative values and the relation to postoperative bleeding and 24-hour transfusion requirements. Results: Fifty patients were included in the study with a significant proportion having complex surgery. Thirteen patients (26%) required blood transfusion (mean rate: 0.5 ± 1 units per patient), 5/50 (10%) received coagulation factors while no patient received fresh frozen plasma, platelets or fibrinogen. Thromboelastometry analysis showed that the major derangement was CT EXTEM > 100 seconds in 28/50 (56%) and A10 EXTEM < 40 mm in one (2%) patient without clinical significance. Platelet function was preserved throughout surgery. A10-FIBTEM was found predictive of postoperative bleeding at 12 hours. Conclusions: MiECC preserves clot quality throughout surgery acting in both key determinants of clot strength; fibrinogen and platelets. This is clinically translated into minimal postoperative bleeding and restricted use of blood products and coagulation factors.


2018 ◽  
Vol 02 (02) ◽  
pp. 084-090
Author(s):  
Vandana Bhardwaj ◽  
Poonam Malhotra Kapoor ◽  
Ameya Anand Karanjkar ◽  
Ujjwal Kumar Chowdhury ◽  
Milind Padmakar Hote ◽  
...  

Abstract Background Patients with cyanotic congenital heart disease (CCHD) have multifactorial hematologic abnormalities. In continuation of our previous study titled “Coagulopathies in Cyanotic Cardiac Patients: An Analysis with Three Point-of-Care Testing Devices (Thromboelastography, Rotational Thromboelastometry, and Sonoclot Analyzer),” we extended this prospective observational study to a larger cohort to reconfirmed the need to do a point-of-care (POC) test in bleeding cyanotic children. We formulated an algorithm. We conducted this study now by comparing three different POC parameters in an algorithm-based manner and deciphering the best parameter from an algorithm-based and the best parameter POC from an algorithm-based perspective. We conducted this study to compare three different viscoelastic POC tests: thromboelastography (TEG), rotational thromboelastometry (ROTEM), and Sonoclot analyzer to predict thrombocytopenia and hypofibrinogenemia in cyanotic cardiac surgery patients. Material and Methods A total of 105 patients of either sex, who were scheduled to undergo elective cardiac surgery for CCHD on cardiopulmonary bypass (CPB), were enrolled after obtaining written and informed consent. Blood samples for TEG, ROTEM, Sonoclot, and standard laboratory coagulation tests were collected after induction of anesthesia (T1) and 30 minutes after protamine reversal (T2). Results We observed significant correlations between POC parameters, platelet count, and serum fibrinogen levels. Area under the curve (AUC, 0.90) of ROTEM FIBTEM-A10 was found to be superior in detecting hypofibrinogenemia (serum fibrinogen < 200 mg/dL). AUC of TEG α angle (AUC 0.79), TEG MA (AUC 0.77) and Sonoclot CR (AUC 0.73) were comparable. Sonoclot PF was found to have highest AUC (0.95) to detect thrombocytopenia (platelet count < 100,000/μL). ROTEM FIBTEM-A10 at cutoff value ≤ 7.5 mm had highest sensitivity (87.2%) and specificity (80.3%) to detect hypofibrinogenemia. Sonoclot PF at cutoff value ≤ 0.95 had highest sensitivity (100%) and specificity (83.7%) to detect thrombocytopenia. We formulated a POC algorithm based on cutoff value derived from ROC curves. Conclusion In conclusion, although all three viscoelastic POC devices (TEG, ROTEM, and Sonoclot) can be used to detect hypofibrinogenemia and thrombocytopenia, it was reaffirmed on a larger subset of patients that ROTEM FIBTEM has highest diagnostic accuracy for hypofibrinogenemia, whereas Sonoclot PF has highest diagnostic value for thrombocytopenia in CCHD surgical patients.


2013 ◽  
Vol 61 (S 01) ◽  
Author(s):  
H Deschka ◽  
M Matthäus ◽  
C Dogru ◽  
S Erler ◽  
G Wimmer-Greinecker

Sign in / Sign up

Export Citation Format

Share Document